NORFOLK, Va. — November is Lung Cancer Awareness Month, and lung cancer remains the leading cause of cancer-related deaths in the United States. The disease often goes undetected until it reaches an ...
Over half of eligible patients are unaware of lung cancer screening services, despite US Preventive Services Task Force recommendations. Low-dose CT scans for lung cancer screening are underutilized, ...
According to the American Lung Association, lung cancer is the leading cause of cancer deaths in the United States. Here in Lee County, four people are diagnosed with lung cancer every day. Lee Health ...
DAKOTA DUNES, S.D. (KTIV) - Providing imaging that could save a life. Since June 2024, the CNOS Imaging Center in Dakota Dunes has provided low-dose CT lung screenings. “This is more of a preventative ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Low-dose CT scans could reduce mortality in lung cancer patients by up to 20 percent, according to a recent study in the New England Journal of Medicine. From Aug. 2002 through April 2004, researchers ...
Low-dose CT screening in a high-risk population detected lung cancer in 2.0% of participants, with nearly 80% of cases diagnosed at stage I or II. The screening protocol demonstrated 97.0% sensitivity ...
A low-dose CT scan is more effective than chest X-rays, doctors say, when it comes to catching lung cancer. A 31-year-old marathon runner thought she had norovirus. She was diagnosed with stage 3 ...
Among eligible populations, screening for breast and colorectal cancers was nearly four times more common than for lung cancer. Among those who never had lung cancer screening, roughly 60% had ...
INDIANAPOLIS — Lung cancer is the deadliest cancer in the United States. Every year, lung cancer claims more lives than breast, prostate and colon cancer combined. The reason is it so deadly? It often ...
Acute radiation morbidities and dosimetric evaluation of DARS structures: Results from the phase III randomized SWOAR trial. This is an ASCO Meeting Abstract from the ASCO Breakthrough: A Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results